OGT Oxford Gene Technology Expands NGS Offering Into Constitutional Cytogenetics Premium The company believes cytogeneticists will adopt its panel to get high-quality SNV and CNV data in a single assay. Sysmex to Acquire Oxford Gene Technology The acquisition allows Sysmex to enter the cytogenetics market and strengthens its technology base in molecular genetics, while expanding its life science business. Oxford Gene Technology Bets on Design, Flexibility to Woo Clinical Labs With New NGS Cancer Panel Premium The British molecular genetics company recently announced a menu update for its SureSeq myPanel NGS Custom Cancer Panel offering. Oxford Gene Technology FY16 Revenues Up 15 Percent The revenue growth comes amid increased demand for the company's molecular genetics products. In Brexit Britain, Genomics Community Anxious About Future EU Funding, Collaboration, Innovation Premium Interviews with leading UK scientists revealed apprehension about losing access to European funding, limitations on freedom of movement, and an exodus of biotechs to the EU. Oct 6, 2015 OGT FISH Kit for Bladder Cancer Gets CE-IVD Mark Sep 10, 2015 Sengenics Buys Oxford Gene Technology's Protein Array Platform Sep 3, 2015 OGT Transfers NGS Services to Source BioScience, Will Focus on Genomic Products Aug 10, 2015 OGT Focuses on Small NGS Cancer Panels for Clinical Research; Will Launch CE-IVD NIPT Array Premium Apr 8, 2015 OGT Aims for May Launch of Next-gen Cytogenic Arrays Premium Feb 3, 2015 For PGS Market Entry, Agilent Draws on Dubai IVF Clinic Partnership, New 16-Plex Array Format Premium Jan 20, 2015 Reproductive Health Science Scales up Array Manufacturing to Support EmbryoCellect Test Premium Dec 2, 2014 OGT's FY2014 Revenues Rise 27 Percent on CytoSure Array, Cytocell FISH Sales, NGS Services Premium Oct 28, 2014 OGT to Commence Clinical Trial for New Array-based Non-invasive Prenatal Test for Down's Syndrome Premium Oct 14, 2014 OGT Sees New Medical Research Exome Array as 'Perfect Complement' to Next-gen Sequencing Workflows Premium Aug 1, 2014 OGT Receives $300K SBRI Grant to Work on New Variant Interpretation Software Product Premium Jul 15, 2014 OGT Expands Pre-implantation Genetic Screening Offering with New Embryo Screen Array Premium May 12, 2014 UK Department of Health Announces SBRI Genomics Grant Winners Apr 1, 2014 OGT Positions New CytoSure Medical Exome Array as Complement to Sequencing-based Tests Premium Mar 28, 2014 Downloads and Upgrades: Sequencher 5.2, Syapse, CytoSure Interpret 4.5.3, and more Premium Mar 25, 2014 New Products: OGT's CytoSure Interpret Software Premium Mar 11, 2014 OGT, Emory Genetics Lab Collaborate on New CGH Arrays Mar 11, 2014 New Products: OGT's CytoSure Molecular Arrays, Golden Helix's SNP & Variation Suite 8 Premium Mar 4, 2014 OGT Complements Chromosomal Microarray Portfolio with Acquisition of FISH Probe Firm Cytocell Premium Mar 4, 2014 OGT Acquires UK FISH Probe Maker Cytocell Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.